Published in Drug Week, November 26th, 2004
The 2004 Annual Survey of Refractive Surgeons found that the non-laser refractive procedure market, as a whole, grew 54.7% over 2003 fueled in part by the expanded indication for NearVision CK. The CK procedure leads the segment with a 73.3% market share, leaving refractive intraocular lens (IOL) implantation at 23.3%.
Minimally invasive and painless, NearVision CK uses radio waves to reshape the cornea and bring near vision...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.